PER 2.47% 8.3¢ percheron therapeutics limited

Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-65

  1. 3,459 Posts.
    lightbulb Created with Sketch. 297
    and the run in October was based off a next bio report/write up, this run is backed by actual positive results from the trial they reported on in October!!

    I can't believe we're still under 10c, however hopefully this time around we hold these levels and build as positive news continues to flow.

    Wonder if Sarepta have read the announcement
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.3¢
Change
0.002(2.47%)
Mkt cap ! $74.82M
Open High Low Value Volume
9.0¢ 9.0¢ 8.2¢ $9.57K 112.6K

Buyers (Bids)

No. Vol. Price($)
2 124862 8.1¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 11000 1
View Market Depth
Last trade - 15.56pm 29/03/2024 (20 minute delay) ?
Last
8.2¢
  Change
0.002 ( 0.86 %)
Open High Low Volume
8.2¢ 8.3¢ 8.2¢ 31700
Last updated 15.55pm 29/03/2024 ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.